Article
Immune responses in pancreatic cancer may be restricted byprevalence of activated…
medRxiv · 2021 · Shivan Sivakumar
Key facts
| Title | Immune responses in pancreatic cancer may be restricted byprevalence of activated regulatory T-cells, dysfunctionalCD8+ T-cells, and senescent T-cells |
|---|---|
| First author | Shivan Sivakumar |
| Journal | medRxiv |
| Published | Jan 13, 2021 |
| DOI | 10.1101/2020.06.20.163071 |
| Devices mentioned | BK110039 |
| Product codes mentioned | KIT, MVU, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1